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ABSTRACT Although investigations regarding surgery for acute ischemic
stroke span 4 decades, the topic remains controversial. This review considers
emergency carotid surgery for acute stroke from four perspectives: an operation
attempting to reverse an acute neurological deficit, an operation soon after
acute stroke to prevent further neurologic deficit, reoperative surgery for acute
neurological deficit early after carotid endarterectomy (CEA), and management
of severe carotid stenosis after successful thrombolytic therapy for acute
ischemic stroke. The available clinical data are absent or incomplete for each of
these unusual aspects of carotid surgery. In the absence of a badly needed ran-
domized trial, case selection is important and should be accompanied by a
proven record of successful, low-morbidity, elective carotid surgery before
undertaking more controversial indications. Delaying CEA for 4 to 6 weeks
after stroke has repeatedly been shown to be unnecessary and to increase risk of
interval new stroke. Finally, the impact of new thrombolytic treatment upon
reoperative surgery for complications of CEA and for planning semielective
reconstructive surgery needs to be considered.
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Surgery for acute ischemic stroke remains a controversial subject. Although
investigations into this topic span 4 decades, the data we rely on for decision-
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making guidance are unclear and often contradictory. In the early 1990s,
panels convened by the Joint Council of the Society for Vascular Surgery, the
North American Chapter of the International Society for Cardiovascular
Surgery, and the American Heart Association could not develop firm conclu-
sions regarding surgery for acute stroke based on the available data.1,2
Although recommendations were made for a randomized trial, to date no
trials have been successfully implemented.
Indeed, prospects for a well-conceived randomized trial appear daunting.
Mead et al attempted a randomized pilot study to ascertain whether urgent
carotid surgery for acute stroke provided better outcomes than best medical
care.’ During the 2-year study period, only 16 patients were eligible for ran-
domization from a total of 593 patients assessed. To replicate this trial with
enough statistical power to detect a 20% improvement in outcome, a study
would require 92 subjects. Assuming conditions similar to those of Mead’s
study, over 3400 patients would have to be assessed (0.05 a, 0.95 (3,
unpaired t-test, difference of 0.20, 3 standard deviations). It is apparent
that, although a randomized trial is justified by medical need and ethical
standpoints, there are significant management and cost issues that would
have to be resolved before a multicenter trial could be accomplished. There-
fore, decisions concerning surgery for acute stroke must be based on avail-
able clinical data.
This review considers emergency carotid surgery for acute stroke from four
perspectives: an operation attempting to reverse an acute neurological deficit, an
operation soon after acute stroke to prevent further neurologic deficit, reop-
erative surgery for acute neurological deficit early after CEA, and manage-
ment of severe carotid stenosis after successful thrombolytic therapy for acute
ischemic stroke. Each of these unusual aspects of carotid surgery present
unique challenges that require careful judgment. The available clinical data
are absent or incomplete for all of them.
SURGERY WITH THE INTENTION OF REVERSING
NEUROLOGICAL DEFICIT
Timing is a critical factor when considering surgery for the purpose of
reversing or reducing a neurological deficit. Unfortunately, there are very
little data that document the limits of critical timing between occlusion of
the internal carotid artery (ICA) and attempts to restore blood flow that are
successful for both hemodynamic and neurologic results. The notion that
interruption of cerebral blood flow results in cellular death within minutes is
simplistic and fails to recognize the clinical implications of the ischemia
penumbra concept. A full discussion of this topic is beyond the intent of this
article. There are experimental animal data, and clinical data consistent with
them, to support the notion that a zone of cerebral tissue ischemia exists
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after acute arterial occlusion that may be reversed by timely intervention.
The temporal limits of potential reversibility are not well defined in humans,
not practically identifiable by any existing test methods, and probably have
individual variability. An arbitrary selection of less than 4 hours from onset
of neurological symptoms has been applied by some,’ but others have
allowed longer intervals.5
One problem that pervades urgent intervention for stroke is the inability
to know whether a deficit treated by carotid surgery within a few hours
would have spontaneously cleared without surgery at all. Although it is true
that most transient ischemic attack (TIA) symptoms clear within minutes to
less than 2 hours, the literature continues to apply the criterion of 24 hours
to define transient ischemia. Certainly, if carotid surgery is being contem-
plated specifically for the purpose of attempting to reverse an acute neuro-
logical deficit, reducing delay makes obvious theoretical sense. Early reports
of successful interdiction of evolving stroke by emergency carotid surgery
include the completely successful outcome in 26 patients reported in 1978.6 6
Emergency carotid surgery was performed in that study, but only qualitative
retrospective neurological assessment was provided.
The following criteria should be considered when determining eligibility
for emergency CEA less than 24 hours after stroke: mild to moderate neu-
rological deficit, cardiovascular stability during the period of observation,
and ultrasound or angiography evidence of significant carotid stenosis or
occlusion in the ipsilateral artery. Contraindications to surgery during this
period include profound neurological deficit with or without loss of con-
sciousness, cardiovascular instability, and computerized axial tomography
(CT) scan evidence of major area of infarction or increased intracranial
pressure or hemorrhage.
Investigators have reported varying degrees of success when attempting to
reverse neurological defects via surgery. Meyer et al described 34 patients
with acute onset of profound neurological deficits resulting from acute ICA
occlusion.’ Because all of these patients were already hospitalized for investi-
gation or preoperative preparations, most had surgery within hours of the
cerebrovascular event. Overall, all but two ICAs were reopened, and a major-
ity of patients improved. The death rate was 20.6% (7/34), however. It is
important to note that 16 of 34 patients (47%) with any neurological
improvement were operated on in 6 hours or less, the majority in less than 4
hours. Of the seven deaths only two were due to cerebral hemorrhage, and
both of these were operated upon within 6 hours. The specter of brain hem-
orrhage has cast a very dark shadow on emergency carotid surgery since the
early reports of Wylie and Rob soon after carotid reconstructive surgery was
described.’,’ However, so much improvement in hospital care, blood pressure
control, and technical vascular surgery has occurred in the past 30 years that
the subject can legitimately be kept open today.
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Such studies provide a registry of cases, not a clinical trial, and the results
do not form a foundation for recommendation as a proven treatment for the
following reasons:
1. Neurological deficit scoring is not used.
2. The length of time from onset of neurological deficit is poorly
recorded.
3. The length of time postoperatively required for neurological improve-
ment is virtually undescribed.
4. Medical therapy alone in stroke patients with mild/moderate neuro-
logical deficit results in improvement in a majority of patients within
2 weeks.
The grading and classification of acute neurological deficits are somewhat
vague and poorly understood by many vascular surgeons. Part of the diffi-
culty is the lack of observer continuity. In a typical case, stroke symptoms may
be described variably by the patient, the family, emergency department
exams, primary physicians, neurologists, and hospital nurses performing
neurological assessments. The terms stroke in evolution, progressive stroke,
stuttering stroke, fluctuating deficit, reversible ischemic neurologic deficit,
acute stroke with rapid improvement, and crescendo TIA have all been used
to indicate how unstable neurological conditions thought due to ischemia
are described.
Although there is not full agreement in the existing literature, many expe-
rienced clinicians advise against considering emergency surgical therapy for
any acute neurological deficit. Others suggest excluding patients with pro-
gressive neurological deficit as distinct from fluctuating ones with intervals of
clearing. In the controversial and completely unsettled area of carotid surgery
to relieve stroke, the surgeon contemplating emergency intervention should
be cautious. The scrutiny of surgical results in carotid disease has been appro-
priately heightened in recent years by published results of low morbidity and
mortality rates from many centers accompanied by guidelines from inter-
disciplinary national sources. Therefore, before embarking on aggressive
emergency surgery, it would seem prudent to establish an experience with
successful CEA for traditional, conservative indications.
SURGERY TO PREVENT DEFECTS
CEA is often delayed for 4 to 6 weeks after the onset of stroke. This approach
is largely based on reports from the 1960s that had poor outcomes and high
mortality for the operation in acute stroke patients.’ Reaction to cautionary
early reports of experience with emergency surgery lead to adoption of a con-
servative approach with an arbitrary delay between onset of the stroke and
subsequent carotid surgery. The interval of 6 weeks became a widespread
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standard but lacked a clinically validated basis. One of the early suggestions
that arbitrary delay might be unnecessary in all patients and accompanied by
significant risk came from Dosick et al, who observed that 4 of 19 patients
(21%) sustained a second denser episode during the 4- to 6-week waiting
period.&dquo; He and his colleagues used CT scans of the brain to determine tim-
ing of CEA in stroke patients; 245 patients with acute stroke underwent
brain CT 1 and 5 days after the initial event. Seventy percent ( 171 patients)
were found to have negative CT, and 64% (110 patients) had appropriate
carotid lesions for surgery demonstrated by angiography. All 110 patients
underwent CEA within 14 days (mean 10 days) and only 1 postoperative
stroke was observed. Meanwhile, among the 30% (74 patients) with CT pos-
itive scans and a 4- to 6-week waiting period before CEA, 9.5% (7 patients)
suffered recurrence of cerebral infarction with 1 death. Ricotta et al had a
similar encouraging result among 17 CT negative patients undergoing
urgent CEA in less than 10 days after the onset of stroke. 11
Sacco et al studied 1273 patients with cerebral infarction as part of the
Stroke Data Bank of the National Institute of Neurological Disorders and
Stroke (NINDS).12 The risk of reinfarction within 30 days after the first onset
of stroke due to carotid stenosis or occlusion was 7.9%. Among the 103
medically treated patients in the North American Symptomatic Carotid
Endarterectomy Trial diagnosed with symptoms of stroke or severe stenosis,
4.9% had a recurrent ipsilateral stroke within 30 days after entry into the trial.
Gasecki et al reviewed 100 CEA patients after they suffered nondisabling
strokes.&dquo; The patients were classified into 2 groups: 42 patients who under-
went CEA within 30 days after stroke and 58 patients who underwent oper-
ation beyond 30 days after stroke. The morbidity and mortality were
comparable in these two groups. The investigators concluded that delaying
surgery in such cases may needlessly place patients at a risk for a recurrent
stroke.
Piotrowski et al performed CEA at variable intervals in 129 patients after
stroke. The investigators suggested that, using a plateau of neurological
recovery, early CEA can be performed with no increase in morbidity and
mortality.i4 An arbitrary delay of 6 weeks was not required to prevent periop-
erative complications. Whittemore et al also had a good result of early CEA
in patients with small, stable stroke and significant carotid stenosis (>75%) Y
In stable, nondisabling stroke with or without small infarction documented
in brain CT, delaying 4 to 6 weeks will put patients at 4.9% to 21% risk of re-
infarction and does not prevent perioperative neurological complications.
Patients whose neurological deficit has cleared or become stable with a mod-
erate deficit arising ipsilateral to carotid stenosis are at risk of further functional
loss. Prompt operation should be considered in those with cardiovascular
stability and absence of CT evidence of major infarction, hemorrhage, or
intracranial pressure increase on an appropriately timed examination.
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STROKE AFTER SUCCESSFUL CAROTID ENDARTERECTOMY
Patients who sustain a new neurological deficit following CEA represent a
special category in the management of acute stroke in many respects. First,
their neurological status is both well known and subject to intensive observa-
tion. Most new neurological deficits after carotid surgery occur within 2 to 4
hours, and almost all deficits occur within 24 hours. Patients who have sus-
tained a stroke followed by good functional recovery after CEA under gen-
eral anesthesia often appear to briefly demonstrate their previous neurological
deficit or parts of it during emergence from anesthesia. This finding resolves
quickly in the recovery room but should be kept in mind. However, in gen-
eral, the acute neurological deficit after CEA follows a period during which
time the patient has been alert and neurologically stable in comparison to
their preoperative status.
There are many causes of early postoperative stroke, and these have been
usefully classified by Riles et al into five categories of 20 different mecha-
nisms.l6 Most, however, will be an acute neurological change within hours
of straightforward CEA. Modern carotid surgery has achieved very low rates of
early postoperative stroke, so their management is not a matter of routine. 17-20
Thus, there is a tendency for individual evaluation to occur that may result in
significant time spent obtaining external ultrasound (performed under diffi-
cult technical circumstances) or worse, arteriography. Although not everyone
agrees, most recent reports have supported the strategy of immediate reoper-
ation without diagnostic procedures other than bedside clinical evaluation by
the operating surgeon.
Proponents of detailed CEA completion imaging by angiography or oper-
ative ultrasonography may doubt that a technical fault will be found that can
be corrected by reoperation. However, this leaves unapproached the issue of
platelet aggregates collecting on the fresh endarterectomy surface of an other-
wise technically perfect operation.
Technical Points in Carotid Surgery for Acute Stroke
Detailed information about technical surgery is best left to an atlas format,
but some aspects seem relevant to this discussion. The presence of an acute
thrombosis or a partially occluding thrombus sometimes found during arte-
riography, together with early reoperation, all require the greatest sensitivity
to disciplined, careful tissue handling during the procedure. A strict &dquo;no-
touch&dquo; technique with clamping of the ICA before any manipulation aids
embolism protection. Often cerebral collaterals will provide enough arterial
back pressure to &dquo;blow out&dquo; a thrombus from the unclamped, opened ICA.
The use of balloon catheters for distal thrombus extraction is dangerous but
may be attempted if kept below the level of the carotid sinus where iatrogenic
trauma, even with a delicate touch, may produce arteriovenous fistula.
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The possibility of heparin antibody reaction should be considered in the
post-CEA patient being returned to the operating room. Even if the preced-
ing CEA was the patient’s first cardiovascular operation, prior exposure to
heparin may have occurred because of its ubiquitous quality in modern hos-
pitals. Therefore, the reflex administration of heparin while returning the
patient to the operating room may have its hazards. The use of low molecu-
lar weight dextran with a loading dose begs the question until the artery can
be opened. The presence of the typical clumping of pinkish gray platelet
aggregates in the endarterectomy site, together with absence of an identifi-
able technical fault that is correctable, makes the presumptive diagnosis of
heparin antibody-induced platelet aggregation advisable until subsequent
tests can be done. Vigorous local measures to clean the endarterectomy
surface should include local irrigation with low molecular weight dextran
as well.
The adjunctive use of thrombolytic drugs during carotid surgery has
recently been reported by Comerota and Eze, whose patient sustained an
acute hemiplegia initially detected upon awakening after CEA.21 Finding no
technical flaw and a patent ICA, they infused 1 million units of urokinase
over 1 hour to treat an occluded anterior communicating artery shown on
operative arteriography. The resolution of the hemiplegia was immediate,
although the patient sustained cerebral infarction in the posterior circulation
demonstrated later.
PATIENTS WITH ACUTE STROKE RESOLVED BY
THROMBOLYTIC THERAPY
Increasing reports of successful thrombolytic treatment for acute stroke are
appearing, with successful recanalization of various cerebral blood supply ves-
sels reported.22-24 The NINDS tissue plasminogen activator trial describes
&dquo;large vessel&dquo; occlusive disease in 252 of 624 randomized patients followed
for 3 months. 21 Unfortunately, extracranial carotid disease is not specifically
identified in this report. The report also does not inform whether any of
these patients received anticoagulation treatment beyond the initial 24 hours
when its use was apparently proscribed by the study protocol. The experience
reported by del Zoppo et al describes 57.7% resolution of acute occlusion in
26 patients treated with rpro-UK, although with a doubling of cerebral hem-
orrhage risk to 15.4% compared with placebo .2’ They only recognized inter-
nal carotid occlusion in 8% of patients.
The advent of this approach to management of acute stroke seems certain
to uncover a significant number of patients who will be found to have a
severe carotid stenosis after the neurological deficit has been cleared. This
presents a new category of patients for the vascular surgeon to consider.
Given the increased risk of cerebral hemorrhage that has accompanied the
beneficial results of these thrombolytic trials, and the likelihood that if
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carotid stenosis is present it will be very severe, will the risk of restoring nor-
mal blood pressure perfusion be increased? In the absence of data, it would
seem that this special circumstance represents an area where conservatism is
appropriate and a period of stabilization with or without anticoagulation
might be prudent.
CONCLUSION
The message of the reported experience in recent years is that acute stroke is
an area where carotid surgery has a contribution to make in resolving neuro-
logical deficit. In the absence of a badly needed randomized trial, case selec-
tion is important and should definitely be accompanied by a proven record of
successful, low-morbidity, elective carotid surgery before undertaking more
controversial indications.
Delaying CEA for arbitrary intervals of 4 to 6 weeks after stroke has
repeatedly been shown to be unnecessary and to increase risk of interval new
stroke.
The impact of new thrombolytic treatment upon reoperative surgery for
complications of CEA and for planning semielective reconstructive surgery
needs to be considered.
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